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Abstract
Background: Metabolic Syndrome (MetSd) is a cluster of vascular risk factors that may influence cerebrovascular
pathology during aging. Recently, microstructural white matter (WM) changes detected by diffusion tensor imaging
(DTI) and processing speed deficits have been reported in MetSd patients. We aimed to test the relationship
between WM alteration and cognitive impairment in these patients.
Methods: The sample comprised 38 subjects (19 patients aged between 50 and 80 years old, and 19 controls). All
patients fulfilled National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP-III) criteria for MetSd.
Speed of information processing was measured by the Symbol Digit Modalities Test (SDMT) and reaction time (RT)
on the Continuous Performance Test (CPT-II) and the Grooved Pegboard Test (GPT). DTI images were acquired in a
3 Tesla Siemens Trio scanner. Voxelwise statistical analysis of the fractional anisotropy (FA) data was performed
using the Tract-Based Spatial Statistics part of the FMRIB Software Library. A correlation analysis was performed
between processing speed variables and FA values.
Results: There was a larger proportion of slow subjects (percentile below 25
th) in the patient group (Chi
2 = 7.125
p = 0.008). FA values correlated positively with SDMT in anterior and posterior parts of the corpus callosum, and RT
CPT-II correlated negatively with FA values in the anterior corpus callosum (p < 0.05 corrected) in the patient
group.
Conclusion: We found significant correlations between WM alterations and cognitive impairment in MetSd
patients, especially in the frontal lobe. These findings highlight the importance of MetSd prevention and control
due to its association with structural and functional damage in the central nervous system.
Background
Metabolic Syndrome (MetSd) is a cluster of risk factors
including hypertension, hyperglycemia, dyslipidemia,
and central obesity associated with cardiovascular dis-
ease. The prevalence of MetSd is increasing in modern-
day societies and the condition is now very common
during aging [1].
Recent DTI studies have shown region-specific pat-
terns of WM alterations, such as myelin loss and axon
degeneration in humans [2,3] and animals [4,5].
Among the DTI indexes, FA has been defined as a
measure of tract directionality and integrity. Decreases
in FA have been observed in association with aging [6],
especially in the frontal lobe [7]. Moreover, FA decrease
has been related with changes in other diffusion mea-
sures such as axial diffusivity (AD), radial diffusivity
(RD) and mean diffusivity (MD). The specific combina-
tions of these variables are related to microstructural
deterioration mechanisms in ageing. For instance
chronic WM degeneration, demyelination, subtle micro-
structural alterations, secondary Wallerian degeneration
and gliosis or early axonal injury [2].
In spite of the increasing importance of MetSd in the
aging process, the association of the condition with
brain damage and cognitive performance has not been
widely studied.
Previous magnetic resonance imaging (MRI) studies
report some evidence of the effect of MetSd on the
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any medium, provided the original work is properly cited.brain, especially in WM. These studies describe the pre-
sence of periventricular hyperintensities, subcortical
WM lesions [8] and silent lacunar infarcts [9] in MetSd
samples. In a recent DTI study [10] of MetSd patients,
we found an anterior-posterior pattern of deterioration
in WM with reduced fractional anisotropy (FA) and
increased apparent diffusion coefficient (ADC) values.
T h ep r e s e n c eo fm i c r o a n g i o p a t h i e si sf r e q u e n ti nt h e
elderly and constitutes an independent risk factor for
recurrent vascular events and cognitive impairment.
Today, there is growing interest in the study of the early
phases of small vessel disease, and the follow-up of pro-
dromal states of pathology may help to identify the fac-
tors that influence the progression.
Moreover, some authors associate MetSd in aging with
high risk of dementia [11], fronto-subcortical symptoms
[12,13] and poorer neuropsychological performance
[14,15]. In a recent study, we found differences between
MetSd and control groups in processing speed and in
some executive functions, after controlling for the influ-
ences of education and gender[15]. Our results sug-
gested that MetSd may be a prodromal state of vascular
cognitive impairment. In recent studies, slower proces-
sing speed in MetSd patients is the most consistent
finding [16], even when the subjects are relatively
young [15].
To the best of our knowledge, the relation between
WM alterations and neuropsychological profile in
MetSd patients has not been studied to date.
Relationships between the loss of WM integrity and
slowed processing speed have been shown in healthy
people [17] and neurological disorders, and the impor-
tance of corpus callosum preservation in good signal
transduction has been stressed [18]. Processing speed is
a basic cognitive or brain processes that subserves many
other higher-order cognitive domains. The speed with
which an individual performs a cognitive activity is not
simply a function of the processes required in that activ-
ity but also a reflection of his or her ability to carry out
many different types of processing operations. Slowing
with age is often considered one of the best-documented
and least controversial behavioural phenomenon of
aging [19]. As a basic process that is dependent on basic
neuronal function and glial support, any sort of focal or
diffuse injury to the brain can affect processing speed.
In central nervous system oligodendrocytes are the glial
cell responsible to myelin sheath formation. Myelin acts
as insulator and it accelerates the neural signal through
the axons, therefore it is crucial to modulate the speed
of signal transduction [20]. When WM is disrupted then
processing speed is in danger to be affected [18,21].
In this study, we hypothesize that MetSd slowness,
evidenced by neuropsychological assessment, would
be associated with subtle FA decreases. To test this
possibility we performed a correlation study between FA
and processing speed variables using DTI.
Methods
Subjects
The study included thirty-eight subjects from two public
medical centers in Cerdanyola del Vallés and Sant Just
Desvern in the province of Barcelona (Spain). The pre-
sent sample participated in two previous works [10,15]
We recruited 19 MetSd and 19 controls. To be diag-
nosed with MetSd, participants had to fulfill at least 3
out of 5 criteria listed in Table 1 (NCEP criteria) [22].
The criterion for selecting controls was the absence of
any vascular risk factors included in the MetSd criteria.
All the participants were volunteers, right-handed, and
aged between 50 and 80 years old. The exclusion criteria
for both groups and details of the methods used have
been explained elsewhere [2].
T h es a m p l ec o m p r i s e dap a t i e n tg r o u po fe l e v e n
women and eight men with mean age 61.26 years (SD =
7.19) and mean years of education 10.37 (SD = 3.55),
and a control group of eleven women and eight men
with mean age 59.63 years (SD = 5.37) and mean years
of education 11.68 (SD = 3.59).
All enrolled subjects gave written informed consent
prior to taking part in the study, and the research was
conducted in accordance with the Helsinki Declaration.
The study was approved by the ethics committee of the
University of Barcelona.
Neuropsychological examination
All participants underwent a comprehensive neuro-
psychological examination performed by a trained neu-
ropsychologist (B.S.). Intelligence quotient was estimated
Table 1 Metabolic Syndrome criteria
Measure Categorical Cut-off points
Elevated waist
circumference
≥ 102 cm in men
≥ 88 cm in women
Elevated triglycerides ≥150 mg/dL
or
On drug treatment for elevated triglycerides
Reduced HDL-Cholesterol < 40 mg/dL in men
< 50 mg/dL in women
or
On drug treatment for reduced HDL-
cholesterol.
Elevated blood pressure ≥ 130 mm Hg systolic blood pressure
or
≥ 85 mm Hg diastolic blood pressure
or
On antihypertensive drug treatment.
Elevated fasting glucose ≥ 100 mg/dL
or
On drug treatment for elevated glucose.
HDL: High density lipoproteins
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gence Scale-III.
Several criteria have been proposed to guide the
selection of measures used to assess processing speed:
relative simple task, the speed measure should not merely
represent the input and output processes or sensory and
motor processes, it is desirable that the construct be eval-
uated with several measures to minimize the specific var-
iance associated with single measures and to emphasize
common construct-relevant variance [19].
We selected processing speed test in base of their sen-
sibility to processing speed changes in previous studies.
The processing speed variables used to test our hypoth-
esis were total correct responses in 90s on the orally-
administered SDMT [23], and time taken to complete
the GPT with dominant and non-dominant hands [23]
and RT on the CPT-II[23].
All the selected tests provide measures of processing
speed. Specifically, the oral SDMT test also involves
divided attention, complex visual scanner tracking, per-
ceptual speed and memory. Theu s eo ft h eo r a lv e r s i o n
avoids motor influences in this processing speed mea-
sure. GPT involves eye-hand coordination and motor
speed: some studies have shown slowed GPT execution
in patients with vascular risk factors [24,25]. Finally,
CPT-II assesses sustained attention to a visual-motor
task and response inhibition. RT measures in this latter
task show the mean response time to the targets [26],
the computerized reaction time measures allow obtain-
ing higher accuracy. All the variables were recorded as
part of a more extensive neuropsychological assessment
described elsewhere [15].
MRI data acquisition
Data acquisition was performed on a 3 Tesla Siemens
Magnetom Trio scanner (Erlangen, Germany), belonging
to the Institut d’Investigacions Biomèdiques August Pi i
Sunyer (IDIBAPS), at the Radiology Service of the Hospi-
tal Clínic of Barcelona. The DTI sequences were acquired
with the following parameters: TR = 5533 ms, TE = 88
ms, acquisition matrix = 122 × 122, field of view (FOV) =
250 × 250 mm
2, diffusion directions = 30, slice thick-
ness = 2 mm, gap distance = 0.6 mm, number of slices =
44, b-values: 0 and 1000 s/mm
2, IPAT factor = 2, total
scan time 3:10 min.
Image pre-processing
Voxelwise statistical analysis of the FA data was carried
out using Tract-Based Spatial Statistics, [27], part of the
FMRIB Software Library [28]. First, FA images were cre-
ated by fitting a tensor model to the raw diffusion data
using FDT, and then brain-extracted using BET [29]. FA
data for all subjects were then aligned into a common
space using the nonlinear registration tool FNIRT
[30,31] which uses a b-spline representation of the
registration warp field [32]. Next, the mean FA image
was created and thinned to produce a mean FA skeleton
(FA threshold to 0.2) which represents the centers of all
tracts common to the group (control or patient). The
aligned FA data for each subject were then projected
onto this skeleton and the resulting data fed into voxel-
wise cross-subject statistics (permutation-based, 5000
permutations).
Assessment of white matter hyperintensity (WMH) burden
The DTI sequence also provides a T2 weighted volume
(B0) which was used to assess WMH. Briefly, a board-
certified neuroradiologist (N.B) rated all images using
the Fazekas scale [33]. The scale is labeled as 0 =
absence, 1 = punctate foci, 2 = beginning confluent of
foci, 3 = large confluent areas.
Statistical analysis
For the analysis of the neuropsychological data, raw data
were first transformed into percentile ranks (pc). The
transformation of raw to percentile scores allows us to
define the threshold which determines slow performance
on cognitive tests in the study-sample (percentile = 25)
in comparison to the normative population. This thresh-
old allows us to detect the amount of subjects with
scores in the fourth quartile of normal distribution.
A qualitative variable was created for each neuropsy-
chological quantitative variable indicating the frequency
of slow participants.
Demographic and neuropsychological variables and
t h ep r e s e n c eo fW M Hi nt h eg r o u p sw e r ec o m p a r e d
using the Statistical Package for the Social Sciences
(SPSS WIN; v.14.0). The Mann Whitney U test was
used for quantitative variables when required, while the
c
2 test was used to analyze qualitative variables. A
p value < 0.05 was considered statistically significant.
Correlations between DTI values and processing speed
variables were examined in the patient and control
groups using the FMRIB software library’s randomized
TFCE (Threshold-Free Cluster Enhancement) option
[34]. In our analyses we used default settings for TFCE
and performed 5000 permutations. A standard general
linear model design matrix was applied using raw
scores. Results were reported at p values < 0.05, cor-
rected. To control the possible effect of age within
group correlations, we performed post-hoc partial corre-
lation analysis between the mean FA of significant clus-
ter and processing speed variable.
Results
There were no differences between the groups in age,
years of education, intelligence quotient estimation or
gender (Table 2). All participants were from the same
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between groups in the period between psychological
testing acquisition and the scan session (t = 1.27 p =
0.312). Mean time in days between both sessions was
mean 75.95 (SD+81.02) in patients and mean 108.21
(S.D+110.40) in controls.
The neuropsychological examination of all controls
showed normal cognitive performance in comparison
with standard population scores. This result ruled out
the possibility of cognitive impairment in any of our
subjects. Patients and controls showed WMH, typically
described in older samples, but there were no differ-
ences between the rates of WHM in the two groups
(Chi
2 = 2.182 p = 0.336).
Comparison of neuropsychological raw data did not
reveal significant differences between groups, even in
processing speed variables (data previously reported in
[2]. However, SDMT and GPT ND identified signifi-
cantly larger proportion of slow-performance subjects
(pc < 25) in the patient group (Table 3). No significant
differences were found comparing the other processing
speed variables.
In the patient group, FA correlated positively with
SDMT in anterior (Table 4 and Figure 1C) and poster-
ior (Table 4 and Figure 1A and Figure 2, 3) regions of
the corpus callosum. RT CPT-II correlated negatively
with FA values in the anterior part of the corpus callo-
sum (Table 4 Figure 1B and Figure 4). No significant
results were found in the control group or in the
inverse contrast. No significant results where found
between groups in FA values (significant coordinates
from correlation analysis). The correlation analysis did
not show significant results in the other variables.
Age is a well known variable related to processing
speed, to control the possible effect of this variable in
the correlation analysis within each group, we per-
formed a partial correlation analysis between the mean
FA value for each significant cluster and the processing
speed measures. We obtained significant results in cor-
relation analysis between SDMT and mean FA measures
in the significant clusters, whilst the correlation between
mean FA measure and CPT II RT show a tendency in
the significant cluster (Table 5).
Discussion
Previous studies have reported relationships between
MetSd and slower processing [15,16] and subtle micro-
structural alterations in WM [10]. In the present study,
there were more slow participants in MetSd group than
in controls group, and their performance correlated with
the FA values obtained by DTI. The correlations were
especially significant in the corpus callosum fibers of the
frontal lobe.
In a study of diabetic patients (type I) Kodl et al.
(2009) [35] reported an association between FA mea-
sures in the corpus callosum splenium, corona radiata
and optic radiation with time taken to copy Rey’s figure
and Grooved Pegboard Test scores. These results indi-
cated a specific effect of a vascular risk factor in regions
involved in processing speed. A recent functional MRI
study of the oral version of the SDMT reported the
involvement of anterior and posterior brain areas in the
task, specifically the occipital lobes (related to the per-
ception of visual attention/scanning) and the fronto-par-
ietal network. The authors associated these latter areas
with processing speed, attention and working memory,
all processes involved in SDMT performance [36]. Simi-
larly, Madden et al. (2009) [37] showed that correlations
between FA and RT of several behavioral measures were
not entirely dependent on perceptual-motor processing
Table 2 Demographic data comparison between groups
Metabolic
Syndrome
Control
Mean (SD) Range Mean (SD) Range U p
value
Age (years) 61.26(7.19) 50-75 59.63(5.37) 51-67 160.5 0.563
Education
(years)
10.37(3.55) 5-16 11.68(3.59) 8-16 138.5 0.223
Vocabulary 42.21(8.651) 28-58 42.89(9.427) 25-60 168.5 0.729
S.D: standard deviation, U: Mann Whitney U test.
Table 3 Cognitive test results
Metabolic Syndrome Control
Cognitive Test Mean(SD) Range Pc < 25 Mean(SD) Range Pc < 25 Chi
2 p value
SDMT 42.63
(15.90)
19-61 6 49.58
(11.57)
31-68 0 7.135 0.008
GPT DH 88.53
(37.88)
59-221 7 72.16
(12.81)
59-110 3 2.171 0.141
GPT NDH 99.74
(41.63)
62-233 8 81.95
(24.22)
55-170 2 4.886 0.027
CPT-II RT 440.53
(71.33)
329-557 8 422.01
(55.23)
322-487 7 0.110 0.740
SDMT = Symbol Digit Modalities Test; GPT = Grooved Pegboard Test, DH = Dominant Hand, NDH = Non Dominant Hand; CPT-II RT = Continuous Performance
Test Reaction time; Pc = Percentile; Chi
2 = Chi square test.
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associated with age-related decline in WM integrity
within specific regions of the fronto-parietal network
(central genu and splenium-parietal fasciculi).
Similarly, the anterior-posterior WM involvement in
our results may also reflect the influence of these
regions in attention and executive processing in the
context of visuomotor control and response regulation,
especially in SDMT and RT CPT-II tasks in which these
processes are more directly involved. In fact, greater cal-
losal integrity allows faster task performance, as a result
of better signal transduction.
Mental slowness also correlated with extended atrophy
in the corpus callosum in normal aging [38] and in sub-
jects with WMH [21], reflecting the relationship
between mental slowness and subcortical white matter
damage.
Recent studies in the elderly corroborate our neurop-
sychological and DTI findings, showing associations
between WM degeneration and slower processing speed
and executive deficits, specifically in the frontal lobe
[17]. Madden et al (2004) [39] also emphasized the
importance of anterior and posterior corpus callosum in
processing speed performance in an adult sample; in
younger adults the best predictor of RT was FA values
in the splenium of the corpus callosum, while in the
elderly it was FA in the anterior limb of the internal
capsule.
The studies reported above showed a relation between
the corpus callosum and processing speed and attention
in the elderly. Although most of these studies controlled
the history of cardiovascular pathology and the effects
of certain vascular risk factors (hypertension, presence
of WMH, diabetes mellitus), they did not control the
presence of other risk factors included in the MetSd
diagnosis such as obesity, insulin resistance and dyslipi-
demia. Despite the fact that the relation between proces-
sing speed measures and FA are influenced by age, our
Table 4 Anatomical regions, where FA correlated with cognitive performance in the MetSd group
Cognitive test Corpus Callosum region Lobe Size MNI coordinates p value r
x y z (corr)
SDMT Right Anterior F 8419 21 29 28 0.016 0.8
Left Posterior 0-T 11331 -33 -44 9 0.015 0.7
CPT-II RT
Left Anterior F 25171 -17 26 22 0.003 0.7
SDMT = Symbol Digit Modalities Test; CPT-II = Continuous Performance Test II; RT = Reaction time; F = Frontal; O = Occipital; T = Temporal; Size = Cluster size at
p 0.05; corr = Corrected; r = Pearson coefficient.
Figure 1 Correlation Results between FA Values and Processing Speed Variables. Figure 1.A, 1.B and 1.C show positive correlation (warm)
between FA values and SDMT performance. Figure 1.B shows negative (cool) correlation between FA and RT CPT-II performance. Images are
represented according to radiological convention (left corresponding to the right hemisphere). R: right, L: left, A: anterior, P: posterior, I: inferior;
S: superior.
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speed deficits and WM alterations in the elderly could
be mediated in some way by the effect of MetSd; since
this relationship was found only in our MetSd patients,
and it was maintained after the post-hoc analysis con-
trolling the possible age effect. Although the specific
mechanism underlying this relationship is not clear,
small-vessel disease may be responsible for the micro-
structural alteration in these patients due to the chronic
state of vascular dysregulation in the brain [40] and
blood brain barrier failure [41]. Some authors have sug-
gested this relationship between vascular risk factors
and pathological pathways such as ischemic cerebral
small-vessel disease, as well as a toxic effect on neurons
caused by the accumulation of advanced glycation end
products and their influence on neurodegenerative
mechanisms. Therefore, vascular risk factors included in
MetSd may influence both cerebrovascular pathology
and neurodegenerative processes [42].
Vascular risk factors are very common in aging, but
when they are present in MetSd they may predispose to
pathological processes and produce a very early state of
deterioration, which makes successful aging more diffi-
cult [43].
DTI is a technique that allows early detection of WM
damage, sometimes even in regions that appear normal
on conventional anatomical images. The present study
shows that the relationship between DTI measures and
cognitive performance allows detection of structural and
functional deficits at an initial state of deterioration,
when patients are prodromal for mild vascular cognitive
impairment. To the best of our knowledge, our results
are the first evidence of vascular involvement in the
neuropsychological performance of MetSd patients
detected by means of neuroimaging.
Figure 2 FA values and SDMT scores (for both patients and
controls) in 21, 28, 29 coordinate significant cluster. Y axis FA
value in 21, 28, 29 coordinate cluster. X axis SDMT scores.
Figure 3 FA values and SDMT scores (for both patients and
controls) in -33, - 44, 9 coordinate significant cluster. Y axis FA
value in -33, -44, 9 coordinate significant cluster. X axis SDMT scores.
Figure 4 FA values and RT CPT-II scores (for both patients and
controls) in -17, 26, 22 coordinate significant cluster. Y axis FA
value in -17, 26, 22 coordinate cluster. X axis RT CPT-II scores.
Table 5 Partial Correlation analysis between mean FA
(within the significant clusters) and cognitive
performance in the MetSd group, controlling age effect
Cognitive test Corpus Callosum
region
MNI coordinates p value r
xyz
SDMT Right Anterior 21 29 28 0.002 0.7
Left Posterior -33 -44 9 0.002 0.7
CPT-II RT
Left Anterior -17 26 22 0.051 0.4
SDMT = Symbol Digit Modalities Test; CPT-II = Continuous Performance Test II;
RT = Reaction time; F = Frontal; O = Occipital; T = Temporal; r = Pearson
coefficient.
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ited in several ways. The most important limitation is
the sample size, due to the high comorbidity of MetSd
and aging with some of the exclusion criteria such as
vascular pathology. Moreover, the increase of sample
size as well as the inclusion of a control group with one
or two vascular risk factors in future work would facili-
tate the analysis of the synergic effects of the vascular
risk factors that comprise MetSd. In addition, as our
design is cross-sectional, follow-up studies of these
patients may show how the profile of cognitive impair-
ment and brain damage evolves using longitudinal
designs.
In conclusion, our study found correlations between
microstructural WM changes and processing speed defi-
cits in MetSd patients using DTI. These results suggest
the existence of a relation between the presence of vas-
cular risk factors and cognitive performance in MetSd
patients. Although other factors contribute to pathologi-
cal aging, MetSd in normal aging may be involved in
these processes and may increase the vulnerability to
pathology.
The prevalence of MetSd is increasing in modern-day
society and its effect is particularly serious in the elderly.
Our results highlight the importance of preventing and
controlling MetSd because of its association with struc-
tural and functional damage in the WM during aging.
Conclusion
We found significant correlations between WM altera-
tions and cognitive impairment of MetSd patients, espe-
cially in the frontal lobe. These findings highlight the
importance of MetSd prevention and control due to its
association with structural and functional damage in the
WM.
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